Globalization and Health

Papers
(The H4-Index of Globalization and Health is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era95
Comprehensive Medical Support in Complex Emergencies (CMSCE): pilot course review88
North Korea’s COVID-19 policy dilemma: epidemic prevention conflicting with trade68
Correction: Assessing the effects of mining projects on child health in sub-Saharan Africa: a multi-country analysis66
Cross-border utilization of cancer care by patients in the US and Mexico – a survey of Mexican oncologists59
Constructing public–private partnerships to undermine the public interest: critical discourse analysis of Working Together published by the International Alliance for Responsible Drinking58
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response58
National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics53
The alcohol industry’s involvement with road safety NGOs50
Capturing sources of health system legitimacy in fragmented conflict zones under different governance models: a case study of northwest Syria49
Rain, rain, go away, come again another day: do climate variations enhance the spread of COVID-19?47
Analysing the impact of trade agreements on national food environments: the case of Vanuatu45
Public health consequences after ten years of the Syrian crisis: a literature review45
Reserve antibiotics: overcoming limitations of evidence generated from regulatory approval trials44
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region42
From isolation to revival: trade recovery amid global health crises42
Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 202040
The politics of glyphosate regulation: lessons from Sri Lanka’s short-lived ban35
Characteristics and outcomes of the drug patent linkage system in China35
Securing the rights and health of domestic workers: the importance of ratifying the ILO’s C18935
Lobbying and nutrition policy in Canada: a quantitative descriptive study on stakeholder interactions with government officials in the context of Health Canada’s Healthy Eating Strategy34
Learning from COVID-19: government leaders’ perspectives to improve emergency risk communication34
Universal coverage of the first antenatal care visit but poor continuity of care across the maternal and newborn health continuum among Nepalese women: analysis of levels and correlates34
Who influences nutrition policy space using international trade and investment agreements? A global stakeholder analysis32
Vaccine nationalism will persist: global public goods need effective engagement of global citizens32
“We have to look deeper into why”: perspectives on problem identification and prioritization of women’s and girls’ health across United Nations agencies31
Food insecurity, COVID-19 and diets in Fiji – a cross-sectional survey of over 500 adults31
Financing of health services for undocumented immigrants in Iran: common challenges and potential solutions30
De-escalation strategies for non-pharmaceutical interventions following infectious disease outbreaks: a rapid review and a proposed dynamic de-escalation framework29
Future health expenditure in the BRICS countries: a forecasting analysis for 203529
0.039990901947021